Overexpression of the Dual Specificity Phosphatase, Cdc25C, Confers Sensitivity on Tumor Cells to Doxorubicin-Induced Cell Death

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-08-0838
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Dual-Specificity Phosphatase DUSP6 Has Tumor-Promoting Properties in Human Glioblastomas

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Cytoprotective Effects of Ferritin on Doxorubicin-Induced Breast Cancer Cell Death

Oncology Reports
MedicineCancer ResearchOncology
2015English

Zoledronate Sensitizes Endothelial Cells to Tumor Necrosis Factor-Induced Programmed Cell Death

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy

Medicinal Research Reviews
Drug DiscoveryMolecular MedicinePharmacology
2013English

Ras Puts the Brake on Doxorubicin-Mediated Cell Death in P53-Expressing Cells.

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

Overexpression of Asparagine Synthetase and Matrix Metalloproteinase 19 Confers Cisplatin Sensitivity in Nasopharyngeal Carcinoma Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

The Dual Specificity Phosphatase Cdc25B, but Not the Closely Related Cdc25C, Is Capable of Inhibiting Cellular Proliferation in a Manner Dependent Upon Its Catalytic Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

16P the Overexpression of SASH1 Stimulates Cell Death in Lung Cancer Cells

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Ras Puts the Brake on Doxorubicin-Mediated Cell Death in P53-Expressing Cells.: FIGURE 1.

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy